Catalyst Wire Dossier Catalyst Wire Dossier

Qinprezo

vosaroxin · Sunesis Europe Ltd
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Qinprezo, covering 2017-08-15 to 2017-08-15. Get the full timeline:

Most recent: EMA Application withdrawn: Qinprezo (vosaroxin) — Sunesis Europe Ltd

See pricing